<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35667743</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8232</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Critical care clinics</Title><ISOAbbreviation>Crit Care Clin</ISOAbbreviation></Journal><ArticleTitle>Acute Neurologic Complications of COVID-19 and Postacute Sequelae of COVID-19.</ArticleTitle><Pagination><StartPage>553</StartPage><EndPage>570</EndPage><MedlinePgn>553-570</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ccc.2022.03.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0749-0704(22)00021-5</ELocationID><Abstract><AbstractText>Neurologic complications can be seen in mild to severe COVID-19 with a higher risk in patients with severe COVID-19. These can occur as a direct consequence of viral infection or consequences of treatments. The spectrum ranges from non-life-threatening, like headache, fatigue, malaise, anosmia, dysgeusia, to life-threatening complications, like stroke, encephalitis, coma, Guillain-Barre syndrome. A high index of suspicion can aid in early recognition and treatment. Outcomes depend on severity of underlying COVID-19, patient age, comorbidities, and severity of the complication. Postacute sequelae of COVID-19 range from fatigue, headache, dysosmia, brain fog, anxiety, depression to an overlap with postintensive care syndrome.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dangayach</LastName><ForeName>Neha S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Neurocritical Care Division, Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, 1 Gustave L, Levy Place, New York, NY 10029, USA; Department of Neurology, Icahn School of Medicine at Mount Sinai, 1 Gustave L, Levy Place, New York, NY 10029, USA. Electronic address: neha.dangayach@mountsinai.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newcombe</LastName><ForeName>Virginia</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University Division of Anaesthesia, Department of Medicine, University of Cambridge, Box 93, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sonnenville</LastName><ForeName>Romain</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, AP-HP, H&#xf4;pital Bichat-Claude Bernard, 46 Rue Henri Huchard, Paris Cedex F-75877, France; Universit&#xe9; de Paris, INSERM UMR 1148, Team 6, Paris F-75018, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Clin</MedlineTA><NlmUniqueID>8507720</NlmUniqueID><ISSNLinking>0749-0704</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="N">Headache</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="Y">Nervous System Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cerebrovascular complications</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Neuro-COVID</Keyword><Keyword MajorTopicYN="N">Neurologic complications</Keyword></KeywordList><CoiStatement>Disclosure The authors have no relevant conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>6</Day><Hour>21</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35667743</ArticleId><ArticleId IdType="pmc">PMC8940578</ArticleId><ArticleId IdType="doi">10.1016/j.ccc.2022.03.002</ArticleId><ArticleId IdType="pii">S0749-0704(22)00021-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19) dashboard  WHO coronavirus (COVID-19) dashboard with vaccination data. https://covid19.who.int/ Available at. Accessed December 9, 2021.</Citation></Reference><Reference><Citation>Wiersinga W.J., Rhodes A., Cheng A.C., et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotta E.M., Batra A., Clark J.R., et al. Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin translational Neurol. 2020;7(11):2221&#x2013;2230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7664279</ArticleId><ArticleId IdType="pubmed">33016619</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683&#x2013;690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Newcombe V.F.J., Dangayach N.S., Sonneville R. 2021. Neurological complications of COVID-19. Intensive care medicine. Published online]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00134-021-06439-6</ArticleId><ArticleId IdType="pmc">PMC8183330</ArticleId><ArticleId IdType="pubmed">34097083</ArticleId></ArticleIdList></Reference><Reference><Citation>Yassin A., Nawaiseh M., Shaban A., et al. Neurological manifestations and complications of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. BMC Neurol. 2021;(1):21. doi: 10.1186/S12883-021-02161-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12883-021-02161-4</ArticleId><ArticleId IdType="pmc">PMC8007661</ArticleId><ArticleId IdType="pubmed">33784985</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur K.T., Miller E.H., Glendinning M.D., et al. COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain. 2021;144(9):2696&#x2013;2708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083258</ArticleId><ArticleId IdType="pubmed">33856027</ArticleId></ArticleIdList></Reference><Reference><Citation>Group P.C.C., Evans R.A., McAuley H., et al. Physical, cognitive and mental health impacts of COVID-19 following hospitalisation &#x2013; a multi-centre prospective cohort study. medRxiv. 2021;22:21254057. doi: 10.1101/2021.03.22.21254057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.22.21254057</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura Z.M., Nash R.P., Laughon S.L., et al. Neuropsychiatric complications of COVID-19. Curr Psychiatry Rep. 2021;23(5):1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7962429</ArticleId><ArticleId IdType="pubmed">33725218</ArticleId></ArticleIdList></Reference><Reference><Citation>Fotuhi M., Mian A., Meysami S., et al. Neurobiology of COVID-19. J&#xa0;Alzheimer&#x2019;s Dis. 2020;76(1):3&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7660990</ArticleId><ArticleId IdType="pubmed">32538857</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldrini M., Canoll P., psychiatry R.K.J. Undefined. How COVID-19 affects the brain. JAMA Psychiatry. 2021;78(6):682&#x2013;683. doi: 10.1001/jamapsychiatry.2021.0500. jamanetwork.com Available at. Published online 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2021.0500</ArticleId><ArticleId IdType="pmc">PMC9894299</ArticleId><ArticleId IdType="pubmed">33769431</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Y., Zhang J., Schiavon C.R., et al. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Circ Res. 2021;128:1323&#x2013;1326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8091897</ArticleId><ArticleId IdType="pubmed">33784827</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T. Neurological infection with SARS-CoV-2 &#x2014; the story so far. Nat Rev Neurol. 2021;17(2):1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7789883</ArticleId><ArticleId IdType="pubmed">33414554</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., L&#xfc;tgehetmann M., Hagel C., et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19(11):919&#x2013;929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.H., Perl D.P., Nair G., et al. Microvascular injury in the brains of patients with covid-19. N&#xa0;Engl J Med. 2021;384(5):481&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehme A.K., Doyle K., Thakur K.T., et al. Disorders of consciousness in hospitalized patients with COVID-19: the role of the systemic inflammatory response syndrome. Neurocrit Care. 2021 doi: 10.1007/s12028-021-01256-7. Published online June 28]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-021-01256-7</ArticleId><ArticleId IdType="pmc">PMC8238027</ArticleId><ArticleId IdType="pubmed">34184176</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Tacquard C., Severac F., et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089&#x2013;1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197634</ArticleId><ArticleId IdType="pubmed">32367170</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S.H., Lindroth H., Perkins A.J., et al. Delirium incidence, duration and severity in critically ill patients with COVID-19. medRxiv. 2020 doi: 10.1101/2020.05.31.20118679. PG-2020.05.31.20118679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.31.20118679</ArticleId><ArticleId IdType="pmc">PMC7690767</ArticleId><ArticleId IdType="pubmed">33251519</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun B.T., Badenes R., Heras La Calle G., et al. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study. Lancet Respir Med. 2021;9(3):239&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832119</ArticleId><ArticleId IdType="pubmed">33428871</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan B.N., Fischer T. Age-associated neurological complications of COVID-19: a systematic review and meta-analysis. Front Aging Neurosci. 2021;13:374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8366271</ArticleId><ArticleId IdType="pubmed">34408638</ArticleId></ArticleIdList></Reference><Reference><Citation>Newcombe V.F.J., Dangayach N.S., Sonneville R. Neurological complications of COVID-19. Intensive Care Med. 2021;47(9):1021&#x2013;1023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8183330</ArticleId><ArticleId IdType="pubmed">34097083</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Fernandez F., Sandoval Valencia H., Barbella-Aponte R.A., et al. Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description. Brain. 2020;143(10):3089&#x2013;3103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454411</ArticleId><ArticleId IdType="pubmed">32645151</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S., Jain R., Dogra S., et al. Cerebral microbleeds and leukoencephalopathy in critically ill patients with COVID-19. Stroke. 2020;51(9):2649&#x2013;2655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7434006</ArticleId><ArticleId IdType="pubmed">32755456</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin E., Lantos J.E., Strauss S.B., et al. Brain imaging of patients with COVID-19: findings at an academic institution during the height of the outbreak in New York City. AJNR Am J neuroradiology. 2020;41(11):2001&#x2013;2008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7658823</ArticleId><ArticleId IdType="pubmed">32819899</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer S., Lersy F., Anheim M., et al. Neurologic and neuroimaging findings in patients with COVID-19: a retrospective multicenter study. Neurology. 2020;95(13):e1868&#x2013;e1882.</Citation><ArticleIdList><ArticleId IdType="pubmed">32680942</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia M.A., Barreras P.v., Lewis A., et al. Cerebrospinal fluid in COVID-19 neurological complications: neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm. J&#xa0;Neurol Sci. 2021;427:117517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8166041</ArticleId><ArticleId IdType="pubmed">34090021</ArticleId></ArticleIdList></Reference><Reference><Citation>Ed&#xe9;n A., Kanberg N., Gostner J., et al. CSF biomarkers in patients with COVID-19 and neurologic symptoms: a case series. Neurology. 2021;96(2):e294&#x2013;e300.</Citation><ArticleIdList><ArticleId IdType="pubmed">33004602</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilmot A., Maldonado Slootjes S., Sellimi A., et al. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients. J&#xa0;Neurol. 2021;268(3):751&#x2013;757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391231</ArticleId><ArticleId IdType="pubmed">32734353</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham E., Ren A., Digby R., et al. Brain injury in COVID-19 is associated with autoinflammation and autoimmunity. medRxiv. 2021;19:2021.</Citation></Reference><Reference><Citation>Savarraj J., Park E.S., Colpo G.D., et al. Brain injury, endothelial injury and inflammatory markers are elevated and express sex-specific alterations after COVID-19. J&#xa0;Neuroinflammation. 2021;18(1):1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8627162</ArticleId><ArticleId IdType="pubmed">34838058</ArticleId></ArticleIdList></Reference><Reference><Citation>Saniasiaya J., Islam M.A., Abdullah B. Prevalence of olfactory dysfunction in coronavirus disease 2019 (COVID-19): a meta-analysis of 27,492 patients. Laryngoscope. 2021;131(4):865&#x2013;878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753439</ArticleId><ArticleId IdType="pubmed">33219539</ArticleId></ArticleIdList></Reference><Reference><Citation>Coolen T., Lolli V., Sadeghi N., et al. Early postmortem brain MRI findings in COVID-19 non-survivors. Neurology. 2020;95(14):e2016&#x2013;e2027.</Citation><ArticleIdList><ArticleId IdType="pubmed">32546654</ArticleId></ArticleIdList></Reference><Reference><Citation>Eliezer M., Hamel A.L., Houdart E., et al. Loss of smell in patients with COVID-19: MRI data reveal a transient edema of the olfactory clefts. Neurology. 2020;95(23):e3145&#x2013;e3152.</Citation><ArticleIdList><ArticleId IdType="pubmed">32917809</ArticleId></ArticleIdList></Reference><Reference><Citation>Paderno A., Mattavelli D., Rampinelli V., et al. Olfactory and gustatory outcomes in COVID-19: a prospective evaluation in nonhospitalized subjects. otolaryngology--head and neck surgery. J&#xa0;Am Acad Otolaryngology. 2020;163(6):1144&#x2013;1149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7331108</ArticleId><ArticleId IdType="pubmed">32600175</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., de Siati D.R., et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngology. 2020;277(8):2251&#x2013;2261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>do Nascimento I.J.B., Cacic N., Abdulazeem H.M., et al. Novel coronavirus infection (COVID-19) in humans: a scoping review and meta-analysis. J&#xa0;Clin Med. 2020;9(4) doi: 10.3390/JCM9040941.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/JCM9040941</ArticleId><ArticleId IdType="pmc">PMC7230636</ArticleId><ArticleId IdType="pubmed">32235486</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian S., Hu N., Lou J., et al. Characteristics of COVID-19 infection in Beijing. J&#xa0;Infect. 2020;80(4):401&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102527</ArticleId><ArticleId IdType="pubmed">32112886</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England) 2020;395(10223):497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Seth V., Kushwaha S. Headache due to COVID-19: a disabling combination. Headache. 2020;60(10):2618&#x2013;2621.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753304</ArticleId><ArticleId IdType="pubmed">33249581</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha-Filho P.A.S., Magalh&#xe3;es J.E. Headache associated with COVID-19: frequency, characteristics and association with anosmia and ageusia. Cephalalgia. 2020;40(13):1443&#x2013;1451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7645592</ArticleId><ArticleId IdType="pubmed">33146035</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehme A.K., Luna J., Kulick E.R., et al. Influenza-like illness as a trigger for ischemic stroke. Ann Clin translational Neurol. 2018;5(4):456&#x2013;463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5899905</ArticleId><ArticleId IdType="pubmed">29687022</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehme A.K., Ranawat P., Luna J., et al. Risk of acute stroke after hospitalization for sepsis: a case-crossover study. Stroke. 2017;48(3):574&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5338564</ArticleId><ArticleId IdType="pubmed">28196938</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkler A., Parikh N., Mir S., et al. Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza. JAMA Neurol. 2020 Published Online.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7333175</ArticleId><ArticleId IdType="pubmed">32614385</ArticleId></ArticleIdList></Reference><Reference><Citation>Majidi S., Fifi J.T., Ladner T.R., et al. Emergent large vessel occlusion stroke during New York City&#x2019;s covid-19 outbreak: clinical characteristics and paraclinical findings. Stroke. 2020;51(9):2656&#x2013;2663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7434004</ArticleId><ArticleId IdType="pubmed">32755349</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxley T.J., Mocco J., Majidi S., et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N&#xa0;Engl J Med. 2020;382(20):e60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7207073</ArticleId><ArticleId IdType="pubmed">32343504</ArticleId></ArticleIdList></Reference><Reference><Citation>Fridman S., Bullrich M.B., Jimenez-Ruiz A., et al. Stroke risk, phenotypes, and death in COVID-19: systematic review and newly reported cases. Neurology. 2020;95(24):E3373&#x2013;E3385.</Citation><ArticleIdList><ArticleId IdType="pubmed">32934172</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaghi S., Ishida K., Torres J., et al. SARS-CoV-2 and stroke in a New York healthcare system. Stroke. 2020;51(7):2002&#x2013;2011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7258764</ArticleId><ArticleId IdType="pubmed">32432996</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsanos A.H., Palaiodimou L., Zand R., et al. Changes in stroke hospital care during the COVID-19 pandemic: a systematic review and meta-analysis. Stroke. 2021;52(11):3651&#x2013;3660. Published online]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8547579</ArticleId><ArticleId IdType="pubmed">34344166</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyden P. Temporary emergency guidance to US stroke centers during the covid-19 pandemic on behalf of the AHA/ASA Stroke Council leadership running title: temporary emergency guidance to US stroke centers. Stroke. 2020 doi: 10.1161/STROKEAHA.120.030023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.030023</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegler J.E., Cardona P., Arenillas J.F., et al. Cerebrovascular events and outcomes in hospitalized patients with COVID-19: the SVIN COVID-19 multinational registry. Int J Stroke. 2021;16(4):437&#x2013;447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7533468</ArticleId><ArticleId IdType="pubmed">32852257</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang J.W., Reynolds A.S., Reilly K., et al. COVID-19 and decompressive hemicraniectomy for acute ischemic stroke. Stroke. 2020;51(9):E215&#x2013;E218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7359903</ArticleId><ArticleId IdType="pubmed">32639861</ArticleId></ArticleIdList></Reference><Reference><Citation>Requena M., Oliv&#xe9;-Gadea M., Muchada M., et al. COVID-19 and stroke: incidence&#xa0;and etiological description in a high-volume center. J&#xa0;Stroke Cerebrovasc Dis. 2020;29(11) doi: 10.1016/J.JSTROKECEREBROVASDIS.2020.105225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JSTROKECEREBROVASDIS.2020.105225</ArticleId><ArticleId IdType="pmc">PMC7405833</ArticleId><ArticleId IdType="pubmed">33066917</ArticleId></ArticleIdList></Reference><Reference><Citation>Dogra S., Jain R., Cao M., et al. Hemorrhagic stroke and anticoagulation in COVID-19. J&#xa0;Stroke Cerebrovasc Dis. 2020;29(8) doi: 10.1016/J.JSTROKECEREBROVASDIS.2020.104984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JSTROKECEREBROVASDIS.2020.104984</ArticleId><ArticleId IdType="pmc">PMC7245254</ArticleId><ArticleId IdType="pubmed">32689588</ArticleId></ArticleIdList></Reference><Reference><Citation>Margos N.P., Meintanopoulos A.S., Filioglou D., et al. Intracerebral hemorrhage in COVID-19: a narrative review. J&#xa0;Clin Neurosci. 2021;89:271&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8096173</ArticleId><ArticleId IdType="pubmed">34119280</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra S., Choueka M., Wang Q., et al. Intracranial hemorrhage in COVID-19 patients. J&#xa0;stroke Cerebrovasc Dis. 2021;30(4) doi: 10.1016/J.JSTROKECEREBROVASDIS.2021.105603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JSTROKECEREBROVASDIS.2021.105603</ArticleId><ArticleId IdType="pmc">PMC7831866</ArticleId><ArticleId IdType="pubmed">33484980</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheruiyot I., Sehmi P., Ominde B., et al. Intracranial hemorrhage in coronavirus disease 2019 (COVID-19) patients. Neurol Sci. 2021 doi: 10.1007/s10072-020-04870-z/.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04870-z/</ArticleId><ArticleId IdType="pmc">PMC7605899</ArticleId><ArticleId IdType="pubmed">33140308</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravindra V.M., Grandhi R., Delic A., et al. Impact of COVID-19 on the hospitalization, treatment, and outcomes of intracerebral and subarachnoid hemorrhage in the United States. PloS one. 2021;16(4) doi: 10.1371/JOURNAL.PONE.0248728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0248728</ArticleId><ArticleId IdType="pmc">PMC8046225</ArticleId><ArticleId IdType="pubmed">33852591</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyrouti R., Best J.G., Chandratheva A., et al. Characteristics of intracerebral haemorrhage associated with COVID-19: a systematic review and pooled analysis of individual patient and aggregate data. J&#xa0;Neurol. 2021;268:3105&#x2013;3115. doi: 10.1007/s00415-021-10425-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10425-9</ArticleId><ArticleId IdType="pmc">PMC7864476</ArticleId><ArticleId IdType="pubmed">33547527</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly S.R., Nguyen A.v., Zhang Y., et al. The relationship between COVID-19 infection and intracranial hemorrhage: a systematic review. Brain Hemorrhages. 2021;2(4):141&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8582085</ArticleId><ArticleId IdType="pubmed">34786548</ArticleId></ArticleIdList></Reference><Reference><Citation>Melmed K.R., Cao M., Dogra S., et al. Risk factors for intracerebral hemorrhage in patients with COVID-19. J&#xa0;Thromb Thrombolysis. 2021;51(4):953&#x2013;960.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7511245</ArticleId><ArticleId IdType="pubmed">32968850</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi A.I., Baskett W.I., Huang W., et al. Subarachnoid hemorrhage and COVID-19: an analysis of 282,718 patients. World Neurosurg. 2021;151:e615&#x2013;e620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8086384</ArticleId><ArticleId IdType="pubmed">33940263</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Mufti F., Amuluru K., Sahni R., et al. Cerebral venous thrombosis in COVID-19: a New York metropolitan cohort study. AJNR Am J neuroradiology. 2021;42(7):1196&#x2013;1200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8324265</ArticleId><ArticleId IdType="pubmed">33888450</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldini T., Asioli G.M., Romoli M., et al. Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysis. Eur J Neurol. 2021;28(10):3478&#x2013;3490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014715</ArticleId><ArticleId IdType="pubmed">33426733</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdalkader M., Shaikh S.P., Siegler J.E., et al. Cerebral venous sinus thrombosis in COVID-19 patients: a multicenter study and review of literature. J&#xa0;Stroke Cerebrovasc Dis. 2021;30(6) doi: 10.1016/J.JSTROKECEREBROVASDIS.2021.105733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JSTROKECEREBROVASDIS.2021.105733</ArticleId><ArticleId IdType="pmc">PMC7931726</ArticleId><ArticleId IdType="pubmed">33743411</ArticleId></ArticleIdList></Reference><Reference><Citation>Kannapadi N.v., Jami M., Premraj L., et al. Neurological complications in COVID-19 patients with ECMO support: a systematic review and meta-analysis. Heart Lung Circ. 2021;31(2):292&#x2013;298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8553269</ArticleId><ArticleId IdType="pubmed">34756659</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeliger B., Doebler M., Hofmaenner D.A., et al. Intracranial hemorrhages on extracorporeal membrane oxygenation: differences between covid-19 and other viral acute respiratory distress syndrome. Crit Care Med. 2022 doi: 10.1097/CCM.0000000000005441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000005441</ArticleId><ArticleId IdType="pmc">PMC9112509</ArticleId><ArticleId IdType="pubmed">35020672</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang C.N., Dettinger J.S., Berchtold-Herz M., et al. Intracerebral hemorrhage in COVID-19 patients with pulmonary failure: a propensity score-matched registry study. Neurocrit Care. 2021;34(3):739&#x2013;747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7899797</ArticleId><ArticleId IdType="pubmed">33619668</ArticleId></ArticleIdList></Reference><Reference><Citation>Pranata R., Huang I., Lim M.A., et al. Delirium and mortality in coronavirus disease 2019 (COVID-19) - a systematic review and meta-analysis. Arch Gerontol Geriatr. 2021:95. doi: 10.1016/J.ARCHGER.2021.104388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.ARCHGER.2021.104388</ArticleId><ArticleId IdType="pmc">PMC7933794</ArticleId><ArticleId IdType="pubmed">33713880</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotta E.M., Batra A., Clark J.R., et al. Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin translational Neurol. 2020;7(11):2221&#x2013;2230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7664279</ArticleId><ArticleId IdType="pubmed">33016619</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Kremer S., Merdji H., et al. Neurologic features in severe SARS-CoV-2 infection. N&#xa0;Engl J Med. 2020;382(23):2268&#x2013;2270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Kremer S., Merdji H., et al. Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients. Crit Care (London, England) 2020;24(1) doi: 10.1186/S13054-020-03200-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S13054-020-03200-1</ArticleId><ArticleId IdType="pmc">PMC7414289</ArticleId><ArticleId IdType="pubmed">32771053</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehme A., Doyle K., Thakur K., et al.   Springer; 2021. Undefined disorders of consciousness in hospitalized patients with covid-19: the role of the systemic inflammatory response syndrome.https://link.springer.com/article/10.1007/s12028-021-01256-7 Available at. Accessed August 1, 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-021-01256-7</ArticleId><ArticleId IdType="pmc">PMC8238027</ArticleId><ArticleId IdType="pubmed">34184176</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdo W.F., Broerse C.I., Grady B.P., et al. Prolonged unconsciousness following severe COVID-19. Neurology. 2021;96(10):e1437&#x2013;e1442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8055315</ArticleId><ArticleId IdType="pubmed">33443134</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer D., Snider S.B., Barra M.E., et al. Disorders of consciousness associated with COVID-19: a prospective, multimodal study of recovery and brain connectivity. Neurology. 2021;98(3):e315&#x2013;e325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8792809</ArticleId><ArticleId IdType="pubmed">34862317</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosey M.M., Needham D.M. Survivorship after COVID-19 ICU stay. Nat Rev Dis Primers. 2020;6(1) doi: 10.1038/S41572-020-0201-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41572-020-0201-1</ArticleId><ArticleId IdType="pmc">PMC7362322</ArticleId><ArticleId IdType="pubmed">32669623</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlake J.H., van Bommel J., Hellemons M.E., et al. Intensive care unit-specific virtual reality for psychological recovery after ICU treatment for COVID-19; a brief case report. Front Med. 2021;7 doi: 10.3389/FMED.2020.629086.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FMED.2020.629086</ArticleId><ArticleId IdType="pmc">PMC7892581</ArticleId><ArticleId IdType="pubmed">33614677</ArticleId></ArticleIdList></Reference><Reference><Citation>Martillo M., Dangayach N., Tabacof L., et al.  Postintensive care syndrome in survivors of critical illness related to coronavirus disease 2019: cohort study from a New York City critical care recovery clinic. Crit Care Med. 2021;49(9):1427&#x2013;1438. https://journals.lww.com/ccmjournal/Abstract/9000/Postintensive_Care_Syndrome_in_Survivors_of.95305.aspx Available at. Accessed July 31, 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">33769771</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousseau A.F., Minguet P., Colson C., et al. Post-intensive care syndrome after a critical COVID-19: cohort study from a Belgian follow-up clinic. Ann Intensive Care. 2021;11(1):1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8319705</ArticleId><ArticleId IdType="pubmed">34324073</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Sullivan O. Long-term sequelae following previous coronavirus epidemics. Clin Med (London, England) 2021;21(1):E68&#x2013;E70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850177</ArticleId><ArticleId IdType="pubmed">33144403</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4(10):e2128568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker A.M., Brigham E., Connolly B., et al. Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care. Lancet Respir Med. 2021;9(11):1328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8525917</ArticleId><ArticleId IdType="pubmed">34678213</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al.  Post-acute COVID-19 syndrome. nature.com. 2021. https://www.nature.com/articles/s41591-021-01283-z Available at. Accessed December 18, 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Goss A.L., Samudralwar R.D., Das R.R., et al. ANA investigates: neurological complications of COVID-19 vaccines. Ann Neurol. 2021;89(5):856.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250888</ArticleId><ArticleId IdType="pubmed">33710649</ArticleId></ArticleIdList></Reference><Reference><Citation>Beatty A.L., Peyser N.D., Butcher X.E., et al. Analysis of COVID-19 vaccine type and adverse effects following vaccination key points&#xa0;+ supplemental content. JAMA Netw Open. 2021;4(12):2140364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8696570</ArticleId><ArticleId IdType="pubmed">34935921</ArticleId></ArticleIdList></Reference><Reference><Citation>Patone M., Handunnetthi L., Saatci D., et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med. 2021;27(12):2144&#x2013;2153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8629105</ArticleId><ArticleId IdType="pubmed">34697502</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegler J.E., Klein P., Yaghi S., et al. Cerebral vein thrombosis with vaccine-induced immune thrombotic thrombocytopenia. Stroke. 2021;52(9):3045&#x2013;3053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8378439</ArticleId><ArticleId IdType="pubmed">34304601</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler M., Tamborska A., Wood G.K., et al. Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorder. J&#xa0;Neurol Neurosurg Psychiatry. 2021;92(11):1144&#x2013;1151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7614639</ArticleId><ArticleId IdType="pubmed">34362855</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>